THRD - Third Harmonic Bio, Inc.
5.15
0 0%
Share volume: 324,398
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$5.15
0.00
0.00%
Summary score
42%
Profitability
35%
Dept financing
26%
Liquidity
50%
Performance
50%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 2021 - 2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-5.47%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
3%
Debt ratio change over timeo
0%
Current Ratio
48.94%
Quick Ratio
0%
Cash Position Ratio
48.17%
Short-term ratios 2024 - 2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-5.85%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
3.08%
Debt ratio change over timeo
0%
Current Ratio
45.36%
Quick Ratio
0%
Cash Position Ratio
44.51%
Last quarter ratios 2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-6.69%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
2.58%
Debt ratio change over time
0%
Current Ratio
54.1%
Quick Ratio
0%
Cash Position Ratio
53.24%
Performance ratios (change over 4 years) 2021 - 2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | THRD | LLY | JNJ | NVO |
---|---|---|---|---|
Return on equity | 0% | 14.28% | 9.23% | 0% |
Return on assets | -5.47% | 4.23% | 3.2% | 0% |
Return on sales | 0% | 27.89% | 25.03% | 0% |
Return on invested capital | 0% | 8.36% | 9.37% | 0% |
Profitability | 0% | 97% | 83% | 0% |
Total debt ratio | 3% | 81.28% | 59.58% | 0% |
Debt ratio change over time | 0% | -11.36% | -57.43% | 0% |
Dept financing | 26% | 25% | 18% | 0% |
Current Ratio | 45.36% | 1.23% | 1.12% | 0% |
Quick Ratio | 0% | 0.95% | 0.88% | 0% |
Cash Position Ratio | 44.51% | 0.12% | 0.5% | 0% |
Liquididy | 50% | 24% | 26% | 0% |
Short-term ratios | THRD | LLY | JNJ | NVO |
---|---|---|---|---|
Return on equity | 0% | 0% | 0% | 0% |
Return on assets | -5.85% | 4.32% | 3.49% | 0% |
Return on sales | 0% | 28.32% | 23.63% | 0% |
Return on invested capital | 0% | 0% | 0% | 0% |
Profitability | 50% | 50% | 41% | 0% |
Total debt ratio | 3.08% | 81.66% | 60.28% | 0% |
Debt ratio change over time | 0% | 0% | 0% | 0% |
Dept financing | 26% | 25% | 18% | 0% |
Current Ratio | 45.36% | 1.23% | 1.12% | 0% |
Quick Ratio | 0% | 0.95% | 0.88% | 0% |
Cash Position Ratio | 44.51% | 0.12% | 0.5% | 0% |
Liquididy | 50% | 26% | 24% | 0% |